This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Osaka University. Active years: 2021-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2023
Title: Masahito Yoshihara: Innovator in Corneal Endothelial Cell Research
Introduction
Masahito Yoshihara is a prominent inventor based in Saitama, Japan. He has made significant contributions to the field of corneal endothelial cell research, focusing on methods for identifying and producing cells suitable for transplantation. His work has the potential to greatly impact the field of regenerative medicine.
Latest Patents
Yoshihara holds 2 patents, with his latest innovations including a corneal endothelial cell marker and methods for producing a cell population suitable for transplantation into the cornea. One of his patents provides a means for identifying cells that are suitable for transplantation into a cornea. This involves preparing a cell population cultured under conditions conducive to inducing differentiation into corneal endothelial cells and measuring the expression of specific genes such as POU6F2, LMX1B, and TFAP2B. His other patent describes a molecular marker that is expressed specifically in corneal endothelial cells, along with methods for producing and evaluating these cells using the marker.
Career Highlights
Yoshihara is affiliated with Osaka University, where he continues to advance his research in the field of cell transplantation. His work is recognized for its innovative approach to addressing challenges in corneal transplantation.
Collaborations
He collaborates with notable colleagues, including Kohji Nishida and Motokazu Tsujikawa, who contribute to his research efforts and enhance the impact of his work in the scientific community.
Conclusion
Masahito Yoshihara's contributions to corneal endothelial cell research exemplify the importance of innovation in medical science. His patents and ongoing research hold promise for improving transplantation techniques and patient outcomes in the future.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
